GSK 319347A
Chemical Name: 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-[[2-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarbonitrile
Purity: ≥98%
Biological Activity
GSK 319347A is a potent and selective IKKε inhibitor (pIC50 = 7.4). Exhibits >100-fold selectivity for IKKε over IKKα IKKβ, and a range of other kinases.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
5-(1H-Benzimidazol-1-yl)-3-alkoxy-2-thiophenecarbonitriles as potent, selective, inhibitors of IKK-ε kinase.
Bamborough et al.
Bioorg.Med.Chem.Lett., 2006;16:6236
Product Datasheets
Citation for GSK 319347A
The citations listed below are publications that use Tocris products. Selected citations for GSK 319347A include:
1 Citation: Showing 1 - 1
-
The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settings.
Authors: Mina J Et al.
Mol Oncol 2022;16:130-147
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for GSK 319347A
There are currently no reviews for this product. Be the first to review GSK 319347A and earn rewards!
Have you used GSK 319347A?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image